Literature DB >> 35913650

Studies on the partial characterization of extracted glycosaminoglycans from fish waste and its potentiality in modulating obesity through in-vitro and in-vivo.

Geetha V1, Moumita Das1,2, Mehrdad Zarei1, Mayookha Vp1,2, Nanishankar V Harohally3, Suresh Kumar G4,5.   

Abstract

Glycosaminoglycans (GAGs) are bioactive polysaccharides or glycoconjugates found in the fish waste having significant health impacts. In the present study it has been attempted to extract GAGs from mackerel fish waste through chemical and enzymatic methods. Further, the extracted GAGs (e-GAGs) were analyzed for their composition (uronic acid, total sugar & sulfate), chemical characterization was carried out through techniques of scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) & Proton NMR. Further, probable major GAGs present was identified by enzymatic digestion. The biological potential of the extracted glycoconjugate was assessed further through in-vitro and in-vivo studies. In-vitro biological activity showed good lipase inhibition (IC50, 2.6 mg/mL) and bile acid binding properties (dose-dependent). Lipid accumulation lowered in the e-GAGs differentiated 3T3L1 preadipocyte cells have also been observed. The high fat fed animal (in-vivo) study showed ameliorative effect via reducing blood sugar∼1.28↓, lipid profile↓, plasma insulin∼3.5↓, improved glucose tolerance, and homeostatic model assessment for insulin resistance (HOMA-IR, ∼3.0↓). Furthermore, elimination of bile acid (BA) due to GAG-BA binding properties resultant in removal of elevated fecal triglyceride and cholesterol suggesting its lipid lowering activity. Regulation of various proteins linked to carbohydrate and lipid metabolism including fatty acid synthase (FAS), low density lipoproteins receptor (LDL-R), 7α-hydroxylase, glucose transporter-4 (GLUT4) and Peroxisome proliferator- activated receptor gamma (PPAR-γ) were significant (p < 0.05) with e-GAGs treatment when compared to HFD group. Thus, the e-GAGs showed potential hypolipidemic activity through elimination of bile acid binding property together with regulating the specific protein related to obesity and its associated complications.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3T3L1 pre-adipocytes; Anti-obesity; Bile acid binding; C57BL/6 mice; Fish waste; Glycosaminoglycans

Mesh:

Substances:

Year:  2022        PMID: 35913650     DOI: 10.1007/s10719-022-10077-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   3.009


  33 in total

1.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

2.  Microheterogeneity of the carbohydrate group of aspergillus oryzae alpha-amylase.

Authors:  J F McKelvy; Y C Lee
Journal:  Arch Biochem Biophys       Date:  1969-06       Impact factor: 4.013

Review 3.  Potential therapeutic application of chondroitin sulfate/dermatan sulfate.

Authors:  Shuhei Yamada; Kazuyuki Sugahara
Journal:  Curr Drug Discov Technol       Date:  2008-12

4.  Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice.

Authors:  Suresh G Kumar; Md Atiar Rahman; Sung Hak Lee; Hee Sun Hwang; Hyun Ah Kim; Jong Won Yun
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

5.  Structural determination of five novel tetrasaccharides containing 3-O-sulfated D-glucuronic acid and two rare oligosaccharides containing a beta-D-glucose branch isolated from squid cartilage chondroitin sulfate E.

Authors:  Akiko Kinoshita-Toyoda; Shuhei Yamada; Stuart M Haslam; Kay-Hooi Khoo; Makiko Sugiura; Howard R Morris; Anne Dell; Kazuyuki Sugahara
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

6.  Effect of bitter gourd and spent turmeric on constituents of glycosaminoglycans in different tissues in streptozotocin induced diabetic rats.

Authors:  G Suresh Kumar; B Vijayalakshmi; P V Salimath
Journal:  Mol Cell Biochem       Date:  2006-03-11       Impact factor: 3.396

7.  The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses.

Authors:  F R Nelson; R A Zvirbulis; B Zonca; K W Li; S M Turner; M Pasierb; P Wilton; D Martinez-Puig; W Wu
Journal:  Rheumatol Int       Date:  2014-06-05       Impact factor: 2.631

Review 8.  Interactions between heparan sulfate and proteins-design and functional implications.

Authors:  Ulf Lindahl; Jin-ping Li
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 9.  The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain.

Authors:  D Trigkilidas; A Anand
Journal:  Ann R Coll Surg Engl       Date:  2013-11       Impact factor: 1.951

Review 10.  Hyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment.

Authors:  Silvia Arpicco; Paola Milla; Barbara Stella; Franco Dosio
Journal:  Molecules       Date:  2014-03-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.